Condensed consolidated statements of operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating loss
Research and development	$ 6,216	$ 1,420	$ 16,557	$ (471)
Acquired in-process research and development		47,716		47,716
General and administrative	3,860	10,380	12,359	15,358
Gain on sale of Aquinox Canada	(7,826)		(7,826)
Total operating loss	2,250	59,516	21,090	62,603
Other income, net	1	384	453	1,262
Net loss	$ (2,249)	$ (59,132)	$ (20,637)	$ (61,341)
Net loss per common stock – basic and diluted	$ (0.04)	$ (2.26)	$ (0.41)	$ (2.51)
Basic and diluted weighted average common shares outstanding	54,121,676	26,185,839	50,896,014	24,429,893